179 related articles for article (PubMed ID: 36291953)
21. Adenocarcinoma of intestinal type of the vulva.
Kurita T; Matuura Y; Hisaoka M; Hachisuga T
Int Cancer Conf J; 2019 Apr; 8(2):89-93. PubMed ID: 31149555
[TBL] [Abstract][Full Text] [Related]
22. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
Park KJ; Bramlage MP; Ellenson LH; Pirog EC
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):8-11. PubMed ID: 18776815
[TBL] [Abstract][Full Text] [Related]
23. Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
Zhao T; Chuang HW; Cornejo KM; Crotty RK; Dahl DM; Wszolek MF; Zlatev DV; Zietman AL; Wu CL
Hum Pathol; 2022 Oct; 128():101-109. PubMed ID: 35926810
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement.
Brambs CE; Horn LC; Mende M; Höckel M; Eckey C; Hiller GGR; Höhn AK
J Cancer Res Clin Oncol; 2022 May; 148(5):1183-1193. PubMed ID: 34495397
[TBL] [Abstract][Full Text] [Related]
26. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
27. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.
Tot T
Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286
[TBL] [Abstract][Full Text] [Related]
28. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
29. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
30. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
Köhler U; Schöne M; Pawlowitsch T
Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
[TBL] [Abstract][Full Text] [Related]
31. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
32. [Update regarding the management of vulvar cancer: The guidelines of the Assistance Publique-Hôpitaux de Paris].
Azaïs H; Pauphilet V; Belghiti J; Nikpayam M; Gonthier C; Maingon P; Conforti R; Uzan C; Canlorbe G;
Bull Cancer; 2019 Apr; 106(4):371-378. PubMed ID: 30898319
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
34. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
35. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
Saad RS; Silverman JF; Khalifa MA; Rowsell C
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):196-201. PubMed ID: 19098678
[TBL] [Abstract][Full Text] [Related]
36. Carcinoma of the Bartholin Gland: A Review of 33 Cases.
Bhalwal AB; Nick AM; Dos Reis R; Chen CL; Munsell MF; Ramalingam P; Salcedo MP; Ramirez PT; Sood AK; Schmeler KM
Int J Gynecol Cancer; 2016 May; 26(4):785-9. PubMed ID: 26844611
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
Sree UD; Prayaga AK; R Reddy VV; Rukmanghadha N; Chowhan AK; Phaneendra BV
Indian J Pathol Microbiol; 2022; 65(1):42-48. PubMed ID: 35074964
[TBL] [Abstract][Full Text] [Related]
38. Primary extramammary invasive Paget's vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?
Tolia M; Tsoukalas N; Sofoudis C; Giaginis C; Spyropoulou D; Kardamakis D; Kouloulias V; Kyrgias G
BMC Cancer; 2016 Jul; 16():563. PubMed ID: 27473174
[TBL] [Abstract][Full Text] [Related]
39. Cloacogenic Adenocarcinoma of the Vulva: A Case Report and Review of the Literature.
Tepeoğlu M; Üner H; Haberal AN; Özen Ö; Kuşçu E
Turk Patoloji Derg; 2018; 34(3):255-258. PubMed ID: 28272666
[TBL] [Abstract][Full Text] [Related]
40. Midline involvement as a risk factor for vulvar cancer recurrence.
Stankevica J; Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
